(Press-News.org) Commercial, rather than patient interests, often drive cancer care and research and patients deserve better, argue a group of global oncologists and patient advocates in a Comment published in The Lancet Oncology journal. The authors also establish core guidelines for the development of a new patient-centred movement in cancer care - Common Sense Oncology.
The Comment says there has been a shift over the past few decades from predominantly publicly funded clinical trials designed to answer questions important to patients, to industry-funded trials which aim to achieve regulatory approval or commercial advantage.
The authors claim industry’s control of the research agenda has created a system that is predominantly focused on new cancer medicines at the expense of investigating new approaches to surgery, radiotherapy, palliative care, and prevention.
The Comment also highlights how a substantial proportion of industry revenue is used for marketing campaigns aimed at influencing patients, policy-makers, and oncologists irrespective of clinical need.
Common Sense Oncology, the new movement launched with the publication of the Comment, aims to ensure that cancer care and innovation is focused on outcomes that matter to patients rather than the commercial bottom line. The authors hope to educate and empower the next generation of oncologists to push the field to do better for patients via three key areas:
Ensuring clinical trials use and report outcomes that matter to patients
Fostering critical thinking among oncologists to make sound clinical decisions aligned with outcomes that matter to patients
Improving patient, public, and policy-maker understanding of cancer treatment options
Prof Christopher Booth, Queen’s University in Kingston, Canada, says, “While many cancer treatments make a real difference in the lives of our patients, there are growing concerns that some new treatments do not help patients live longer or feel better. Common Sense Oncology is a global initiative that prioritises people over profits and promotes shared decision-making with patients. Our Vision is that patients have access to cancer treatments that provide meaningful improvements in outcomes that matter – irrespective of where they live.”
END
THE LANCET ONCOLOGY: Cancer experts call for cancer care to be centred on patients rather than the commercial bottom-line
2023-07-17
ELSE PRESS RELEASES FROM THIS DATE:
Significant rise in ADHD diagnoses in the UK
2023-07-17
Both ADHD diagnoses and prescriptions for ADHD medication have increased significantly over the past two decades, except in children under five, finds a new study by UCL researchers.
The research, published in BJPsych Open, reviewed data from 7 million individuals aged three to 99, from IQVIA Medical Research Data, a UK primary care database, between 2000 and 2018.
Of these individuals, 35,877 had an ADHD diagnosis and 18,518 received prescriptions for ADHD medication from their GP.
Although the number of individuals receiving medication for ADHD is still relatively low, the researchers found ...
New guidelines for diagnosing Alzheimer's
2023-07-16
Today at the International Alzheimer's Congress (AAIC) in Amsterdam, new guidelines for diagnosing Alzheimer's disease developed by clinicians and researchers from around the world were presented. In these criteria, the disease is diagnosed in the clinic through the use of blood biomarkers, just as with other major diseases such as diabetes and cardiovascular disease.
A blood test has been developed for this purpose in recent years that gives very good results, according to recent research. Charlotte Teunissen, professor of neurochemistry at Amsterdam ...
Discovery could lead to more treatments to prevent cancer and infectious diseases
2023-07-16
Researchers have cracked how a particular type of immune cell develops in the body and protects against infection and disease. And the discovery could help in the development of more preventive treatments, according to a new study.
The research, led by Murdoch Children’s Research Institute and Federation University Australia, has uncovered how these specialised white blood cells operate and can produce an immune response.
Associate Professor Dan Pellicci said by understanding the function of these cells, they could be harnessed to help prevent cancer and highly infectious diseases such as ...
Unimolecular reactions of anti-glycolaldehyde oxide and its reactions with one and two water molecules
2023-07-15
Criegee intermediates are produced in the ozonolysis of unsaturated compounds in the atmosphere. These intermediates are especially importanct because they contribute to the formation of OH radical during the night and to formation of secondary organic aerosols. The OH radicals increase the oxidative capacity of the atmosphere, and the aerosols may reflect or absorb sunlight and contribute to cloud formation. Criegee intermediates also lay key roles in conversion of sulfur dioxide into sulfur trioxide, finally resulting in the formation ...
5-aminolevulinic acid might help fight mitochondrial disorders
2023-07-15
Tokyo, Japan – Scientists from Tokyo Metropolitan University have shown that 5-aminolevulinic acid (5-ALA) helps bypass deficiencies in Complex I (CI), the first in a series of protein complexes that transport electrons and help power the mitochondria. They showed that fruit flies missing the analogous protein showed improved health when given a cocktail of drugs including 5-ALA. CI deficiency is responsible for the majority of mitochondrial disorders; the team’s findings might lead to new therapies.
Mitochondrial diseases arise from problems in the mitochondria, a small organelle in cells which produces adenosine triphosphate (ATP), ...
Mobile app enables students with special needs to self-monitor behavior, focus more in class
2023-07-14
COLUMBIA, Mo. -- When Sara Estrapala started her career as a high school paraeducator supporting students with disabilities such as autism, down syndrome, learning disorders and challenging behaviors, she quickly recognized a challenge — her teenage students desire to make their own decisions and their teachers’ struggle to keep them engaged and following directions.
Now an assistant research professor in the University of Missouri College of Education and Human Development, Estrapala is leading a four-year, $519,939 early career development and mentoring ...
Remote plant worlds
2023-07-14
Oceanic islands provide useful models for ecology, biogeography and evolutionary research. Many ground-breaking findings – including Darwin's theory of evolution – have emerged from the study of species on islands and their interplay with their living and non-living environment. Now, an international research team led by the University of Göttingen has investigated the flora of the Canary Island of Tenerife. The results were surprising: the island's plant-life exhibits a remarkable diversity ...
Renewal for university network Enlight
2023-07-14
The European university network Enlight has been renewed: the EU has funded the Enlight Network consisting of the University of Göttingen with nine other research-oriented universities for four more years with a total of around 14.4 million euros. The Network plans to use a large part of the funds for academic initiatives, underlining its commitment to supporting researchers and students. In addition to the University of Göttingen, the Network includes the Universities of Ghent, Groningen, Uppsala and Tartu, the University of the Basque Country, the Universities of Bordeaux and Galway as well as Comenius University Bratislava; and Enlight's tenth and ...
UVA engineer innovates a liquid safety cushioning technology
2023-07-14
The discovery that football players were unknowingly acquiring permanent brain damage as they racked up head hits throughout their professional careers created a rush to design better head protection. One of these inventions is nanofoam, the material on the inside of football helmets.
Thanks to mechanical and aerospace engineering associate professor Baoxing Xu at the University of Virginia and his research team, nanofoam just received a big upgrade and protective sports equipment could, too. This newly invented design integrates nanofoam with “non-wetting ionized liquid," a ...
Your neighborhood may increase risk of hospitalization from respiratory diseases like COVID-19.
2023-07-14
The range of COVID-19 symptoms varies—some feel a mild cold, others are hospitalized, while others perish. Many studies have linked the severity of COVID-19 symptoms with an individual’s biological factors, but less is known about the impact of non-biological factors, such as the environment in which people live.
A new study that published on June 14, 2023, in the journal PLoS ONE, is the first to show that the neighborhood-built environment might pose an independent risk determining the individuals hospitalized due to COVID-19 illness.
The authors found that in a cohort of more than 18,000 individuals with SARS-CoV-2 infections, living in ...